PLA2G5: PA2 catalyzes the calcium-dependent hydrolysis of the 2- acyl groups in 3-sn-phosphoglycerides. This isozyme hydrolyzes more efficiently L-alpha-1-palmitoyl-2-oleoyl phosphatidylcholine than L-alpha-1-palmitoyl-2-arachidonyl phosphatidylcholine, L- alpha-1-palmitoyl-2-arachidonyl phosphatidylethanolamine, or L- alpha-1-stearoyl-2-arachidonyl phosphatidylinositol. May be involved in the production of lung surfactant, the remodeling or regulation of cardiac muscle. Defects in PLA2G5 are the cause of fleck retina, familial benign (FRFB). An autosomal recessive condition associated with a distinctive retinal appearance and no apparent visual or electrophysiologic deficits. Affected individuals are asymptomatic, but fundus examination reveals a striking pattern of diffuse, yellow-white, fleck-like lesions extending to the far periphery of the retina but sparing the foveal region. Belongs to the phospholipase A2 family.
Protein type: Lipid Metabolism - ether lipid; Secreted; Cell surface; Lipid Metabolism - arachidonic acid; EC 3.1.1.4; Lipid Metabolism - glycerophospholipid; Secreted, signal peptide; Phospholipase; Lipid Metabolism - alpha-linolenic acid; Lipid Metabolism - linoleic acid
Chromosomal Location of Human Ortholog: 1p36-p34
Cellular Component: Golgi apparatus; cell surface; perinuclear region of cytoplasm; plasma membrane; extracellular region
Molecular Function: heparin binding; calcium-dependent phospholipase A2 activity; calcium ion binding
Biological Process: leukotriene biosynthetic process; platelet activating factor biosynthetic process; response to cAMP; phospholipid metabolic process; response to cytokine stimulus; glycerophospholipid biosynthetic process; phosphatidic acid biosynthetic process; arachidonic acid secretion; lipid catabolic process
Disease: Fleck Retina, Familial Benign
Show more